Regulatory update preview
Source-linked feed summaries for digital health and medical-device teams.
The current archive contains 20 source records. Search and saved filters are being rebuilt and are not available in this preview.
Pre-submission Advice & Support for Innovative Medicines
MHRA offers a pre-submission service for innovative medicines.
Read source-linked summaryNational assessment procedure for medicines
MHRA source titled National assessment procedure for medicines.
Read source-linked summaryMedicines: apply for a variation to your marketing authorisation
Source describes applying for changes to a marketing authorisation.
Read source-linked summaryGuidance: COVID-19 test validation approved products
This MHRA guidance relates to COVID-19 test validation approved products.
Read source-linked summaryMHRA sets out steps to prevent avoidable harm from patient hoists
A National Patient Safety Alert has been issued related to patient hoists
Read source-linked summaryOpportunities for patients and the public to be involved in the work of the MHRA
Source describes opportunities for patients and the public to be involved in the work of the MHRA.
Read source-linked summaryGuidance: National Patient Safety Alert Supporting Information. Patient hoists and slings: incidents and case examples.
Supporting information to accompany the National Patient Safety Alert on patient hoists and slings NatPSA/2026/005/MHRA.
Read source-linked summaryNational Patient Safety Alert: Patient hoists and slings (all types): risk of death and serious harm from falls (NatPSA/2026/005/MHRA)
Alert covers patient hoists and slings (all types) for risk of death and serious harm from falls.
Read source-linked summaryClinical trials for medicines: Good clinical practice inspections
MHRA source titled 'Clinical trials for medicines: Good clinical practice inspections' was referenced.
Read source-linked summaryMHRA and Malaysia strengthen partnership on healthcare innovation and research
MHRA has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia
Read source-linked summaryField Safety Notices: 7 September to 11 September 2026
MHRA published a list of Field Safety Notices covering 7 September to 11 September 2026.
Read source-linked summaryIndependent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcare
Independent NHS doctor-led Commission has issued a blueprint with new recommendations for AI adoption in healthcare.
Read source-linked summaryResearch: National Commission into the Regulation of AI in Healthcare: Recommendations for a future regulatory framework
The National Commission into the Regulation of AI in Healthcare has published recommendations to advise government on a future regulatory framework for AI in healthcare.
Read source-linked summaryField Safety Notices: 31 August to 4 September 2026
MHRA published a list of Field Safety Notices covering 31 August to 4 September 2026.
Read source-linked summaryDecision: Advertising investigations: August 2026
MHRA published a decision update titled Advertising investigations: August 2026.
Read source-linked summaryCorporate report: MHRA-NICE Real-World Evidence Scientific Dialogue
Described as MHRA-NICE Real-World Evidence Scientific Dialogue programme
Read source-linked summaryDecision: Human and veterinary medicines: register of licensed manufacturing sites
Source is described as the MHRA register of licensed manufacturing sites.
Read source-linked summaryNotice: Register of brokers authorised to deal in human medicines
Notice provides a current listing of UK brokers authorised to broker human medicines.
Read source-linked summaryDecision: Medicines: new manufacturing and wholesale dealer licences
List of sites granted a manufacturer licence for medicines.
Read source-linked summaryNotice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
Notice identifies UK companies with terminated and cancelled licences
Read source-linked summary